We have developed C-STEMTM : a proprietary technology for the mass-production of cell therapies.
Our offer
Cell therapy pipeline
A series of proprietary cell therapy programs for co-development or licensing
Latest news
-
-
TreeFrog in Boston !
TreeFrog Therapeutics’ CEO/CTO, Kevin Alessandri is spending a week in Boston (Novembre 4-9) as part of the New Technology Venture Accelerator (NETVA) program to meet the local deep tech ecosystem. Thanks to the teams of the Science and Technology Department of the French Embassy in the United States......
31 October, 2019 Events News -
TreeFrog Therapeutics at BIG by BPIfrance
Our CSO, Maxime Feyeux, contributed to a roundtable entitled “What breakthrough innovations to develop next-generation bioproduction factories ?” organized by BPI France and Medicen in Paris on October 10th 2019, during the Innogeneration event....
11 October, 2019 Events Video
I am test text for Image with text shortcode. |
TreeFrog Therapeutics I Stem Cell Company I Cell Therapy for all
TreeFrog Therapeutics is a stem cell company based in Bordeaux, France, which aims at supporting the advent and industrial development of stem cell therapies. TreeFrog Therapeutics has developed C-Stem, a technology platform to scale-up cell therapy manufacturing. Based on high throughput stem cell encapsulation, C-Stem enables the mass production of human induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) in bioreactors, as well as their differentiation into the desired cell type. Founded by Kevin Alessandri and Maxime Feyeux, TreeFrog Therapeutics is a startup company which aims at providing access to cell therapies for all.